Table 3:
Univariate Cox Regression Analysis for Overall Survival Over Entire Cohort
Variable | Hazard Ratio | 95% CI (Lower) | 95% CI (Upper) | p-value |
---|---|---|---|---|
Age at Diagnosis | ||||
<50 | 1 | Reference | ||
≥50 | 1.826 | 1.409 | 2.368 | 0.001 |
Gender | ||||
Male | 1 | Reference | ||
Female | 0.989 | 0.799 | 1.223 | 0.918 |
Ethnicity | ||||
White | 1 | Reference | ||
Black | 1.192 | 0.738 | 1.926 | 0.472 |
Hispanic | 1.039 | 0.781 | 1.384 | 0.791 |
Asian/Indian | 0.675 | 0.358 | 1.270 | 0.222 |
Marital Status | ||||
Married | 1 | Reference | ||
Unmarried | 1.117 | 0.882 | 1.415 | 0.358 |
KPS | ||||
≥70 | 1 | Reference | ||
<70 | 3.23 | 2.452 | 4.262 | 0.001 |
Extent of Surgical Resection | ||||
Gross Total Resection | 1 | Reference | ||
Subtotal Resection | 1.698 | 1.182 | 2.440 | 0.004 |
Biopsy | 2.992 | 2.180 | 4.107 | 0.001 |
RPA Class | ||||
III | 1 | Reference | ||
IV | 2.357 | 1.511 | 3.675 | 0.001 |
V/VI | 7.815 | 4.816 | 12.681 | 0.001 |
RT Technique | ||||
IMRT | 1 | Reference | ||
3D CRT | 1.417 | 1.136 | 1.766 | 0.002 |
2D | 4.033 | 2.452 | 6.633 | 0.001 |
RT Total Dose | ||||
<36 Gy | 4.526 | 3.202 | 6.396 | 0.001 |
36–54 Gy | 1.787 | 1.158 | 2.757 | 0.009 |
>54 Gy | 1 | Reference | ||
Laterality | ||||
Unilateral | 1 | Reference | ||
Bilateral | 1.317 | 0.983 | 1.764 | 0.065 |
Multicentricity | ||||
No | 1 | Reference | ||
Yes | 1.311 | 0.995 | 1.727 | 0.054 |
IDH-1 Status | ||||
Negative | 26.362 | 0.296 | 2351.589 | 0.153 |
Positive | 1 | Reference | ||
MGMT Status | ||||
Unmethylated | 1.136 | 0.338 | 3.816 | 0.836 |
Methylated | 1 | Reference | ||
Temozolomide | ||||
Yes | 1 | Reference | ||
No | 2.285 | 1.451 | 3.598 | 0.001 |